# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000906709-20-000009
Filing Date
2020-05-08
Accepted
2020-05-07 21:26:54
Documents
52
Period of Report
2020-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nktr-20200331.htm iXBRL | 10-Q | 1381808
2 | EX-10.1 | nktr2020-03x31ex101.htm | EX-10.1 | 26626
3 | EX-31.1 | nktr2020-03x31xexx311.htm | EX-31.1 | 11239
4 | EX-31.2 | nktr2020-03x31xexx312.htm | EX-31.2 | 11252
5 | EX-32.1 | nktr2020-03x31xexx321.htm | EX-32.1 | 7848
| Complete submission text file | 0000906709-20-000009.txt |  | 5284338

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nktr-20200331.xsd | EX-101.SCH | 41853
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nktr-20200331_cal.xml | EX-101.CAL | 66913
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nktr-20200331_def.xml | EX-101.DEF | 175701
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nktr-20200331_lab.xml | EX-101.LAB | 472438
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nktr-20200331_pre.xml | EX-101.PRE | 282802
27 | EXTRACTED XBRL INSTANCE DOCUMENT | nktr-20200331_htm.xml | XML | 721265

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 20858438
SIC: 2834 Pharmaceutical Preparations